Literature DB >> 21352337

Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea.

Margaret Song1, Sang-Hee Seo, Hyun-Chang Ko, Chang-Keun Oh, Kyung-Sool Kwon, Chulhun L Chang, Moon-Bum Kim.   

Abstract

Propionibacterium acnes plays an important role in the development of acne, and inflammatory lesions are improved by antibiotics. Long-term use of antibiotics may result in development of resistant strains and treatment failure. The aim of the present study was to investigate the isolation rate of P. acnes and to evaluate its antibiotic susceptibility to widely used antibiotics in acne in Korea. Among 46 patients, 31 P. acnes strains were cultured. Isolated P. acnes was measured for minimum inhibitory concentration (MIC) of tetracycline, doxycycline, minocycline, erythromycin and clindamycin using an Epsilometer test. Age, disease duration and previous history of antibiotic therapy for acne were compared in relation to the MIC. The mean MIC of tetracycline, minocyclines, doxycycline, clindamycin and erythromycin were all below the breakpoint of antibiotic resistance. The patients with acne vulgaris with disease duration of more than 2 years documented higher MIC values in doxycycline, erythromycin, and clindamycin than those of less than 2 years. The patients who were previously treated with topical or systemic antibiotics showed higher MIC in doxycycline. Antibiotic resistance of P. acnes is still low in Korea, but at this point, there is an increasing trend of MIC. Caution and acknowledgement of increased risk of antibiotic resistant P. acnes should be advised in acne antibiotic treatment to minimize and avoid the emergence of the resistant strain.
© 2010 Japanese Dermatological Association.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21352337     DOI: 10.1111/j.1346-8138.2010.01109.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  9 in total

Review 1.  Propionibacterium acnes: from commensal to opportunistic biofilm-associated implant pathogen.

Authors:  Yvonne Achermann; Ellie J C Goldstein; Tom Coenye; Mark E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

2.  Status Report from the Scientific Panel on Antibiotic Use in Dermatology of the American Acne and Rosacea Society: Part 1: Antibiotic Prescribing Patterns, Sources of Antibiotic Exposure, Antibiotic Consumption and Emergence of Antibiotic Resistance, Impact of Alterations in Antibiotic Prescribing, and Clinical Sequelae of Antibiotic Use.

Authors:  James Q Del Rosso; Guy F Webster; Ted Rosen; Diane Thiboutot; James J Leyden; Richard Gallo; Clay Walker; George Zhanel; Lawrence Eichenfield
Journal:  J Clin Aesthet Dermatol       Date:  2016-04-01

3.  Antimicrobial susceptibility of Propionibacterium acnes isolates from shoulder surgery.

Authors:  John K Crane; Donald W Hohman; Scott R Nodzo; Thomas R Duquin
Journal:  Antimicrob Agents Chemother       Date:  2013-04-29       Impact factor: 5.191

4.  Inhibition of lipase and inflammatory mediators by Chlorella lipid extracts for antiacne treatment.

Authors:  G Sibi
Journal:  J Adv Pharm Technol Res       Date:  2015 Jan-Mar

5.  Chitosan against cutaneous pathogens.

Authors:  Jackson Champer; Julie Patel; Nathalie Fernando; Elaheh Salehi; Victoria Wong; Jenny Kim
Journal:  AMB Express       Date:  2013-07-06       Impact factor: 3.298

6.  Propionibacterium acnes Susceptibility and Correlation with Hemolytic Phenotype.

Authors:  Travis E Wright; K Keely Boyle; Thomas R Duquin; John K Crane
Journal:  Infect Dis (Auckl)       Date:  2016-10-09

7.  Development and Sequential Analysis of a New Multi-Agent, Anti-Acne Formulation Based on Plant-Derived Antimicrobial and Anti-Inflammatory Compounds.

Authors:  Crina Saviuc; Bianca Ciubucă; Gabriela Dincă; Coralia Bleotu; Veronica Drumea; Mariana-Carmen Chifiriuc; Marcela Popa; Gratiela Gradisteanu Pircalabioru; Luminita Marutescu; Veronica Lazăr
Journal:  Int J Mol Sci       Date:  2017-01-17       Impact factor: 5.923

8.  Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug.

Authors:  Linda Stein Gold; Hilary Baldwin; Leon H Kircik; Jonathan S Weiss; David M Pariser; Valerie Callender; Edward Lain; Michael Gold; Kenneth Beer; Zoe Draelos; Neil Sadick; Radhakrishnan Pillai; Varsha Bhatt; Emil A Tanghetti
Journal:  Am J Clin Dermatol       Date:  2021-10-21       Impact factor: 7.403

9.  Antibiotic Susceptibility of Cutibacterium acnes Strains Isolated from Israeli Acne Patients.

Authors:  Sivan Sheffer-Levi; Amit Rimon; Vanda Lerer; Tehila Shlomov; Shunit Coppenhagen-Glazer; Chani Rakov; Tamara Zeiter; Ran Nir-Paz; Ronen Hazan; Vered Molho-Pessach
Journal:  Acta Derm Venereol       Date:  2020-10-20       Impact factor: 3.875

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.